Injection Routes and Basic Use Peptides can break down in the gut, so injections offer a clean path to tissues
Endocrinology, 2017
While the exact mechanisms of this function are still under investigation, studies indicate that MT-II powerfully affects sexual arousal through the hypothalamus [3, 8, 9]
The future oral GLP-1 receptor agonists, incretin dual agonists, triple agonists, and other new oral metabolic products will become popular only if they prove themselves capable of producing sustained results in obesity disease, type 2 diabetes, hypertension, dyslipidemia, cardiovascular risks, and metabolic syndromes through their effectiveness and safety
Risk Factors Metabolic syndrome (strongest risk factor) increased waist circumference (obesity) insulin resistance elevations in: blood sugar cholesterol triglycerides blood pressure uric acid Diabetes (up to 75% of individuals with type 2 diabetes have NAFLD) Sleep apnea Gut microbiome effects Genetic factors Why is it important to address
10.3390/biom11101478 2 AumannK